FIL Ltd - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIL Ltd ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$1,001,000
-37.8%
36,441
-36.4%
0.00%
-50.0%
Q1 2021$1,609,000
+14527.3%
57,307
+13289.5%
0.00%
Q4 2020$11,000
+120.0%
428
+38.1%
0.00%
Q3 2020$5,0000.0%310
+68.5%
0.00%
Q2 2020$5,000
-99.3%
184
-99.7%
0.00%
-100.0%
Q3 2018$743,000
+14.0%
53,2860.0%0.00%0.0%
Q2 2018$652,000
-20.8%
53,2860.0%0.00%
-50.0%
Q1 2018$823,00053,2860.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders